Europe Breast Cancer Screening Tests Market Share

Statistics for the 2023 & 2024 Europe Breast Cancer Screening Tests market share, created by Mordor Intelligence™ Industry Reports. Europe Breast Cancer Screening Tests share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Europe Breast Cancer Screening Tests Industry

The Europe breast cancer screening test market is moderately competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. With the increasing awareness among the population and rising advances in screening test, a few other smaller players are expected to enter the market and may come to hold a substantial share. Some of the major players in the market are Allengers, Myriad Genetics, Hologic Inc., and Siemens Healthineers, among others.

Europe Breast Cancer Screening Tests Market Leaders

  1. Allengers

  2. Myriad Genetics, Inc.

  3. Siemens Healthineers

  4. Hologic Inc.

  5. GE Healthcare

*Disclaimer: Major Players sorted in no particular order

Europe Breast Cancer Screening Tests Market Concentration

Europe Breast Cancer Screening Tests Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)